alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

                                                                    Exhibit 99.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.ss. 1350)

Pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002 (18  U.S.C.ss.1350),
the  undersigned,  Randall  H.  Pierce,  Chief  Financial  Officer  of Lone Star
Steakhouse & Saloon, Inc., a Delaware  corporation (the "Company"),  does hereby
certify, to his knowledge, that:

The  Quarterly  Report on Form 10-Q for the period  ended  March 25, 2003 of the
Company (the "Report") fully complies with the  requirements of Section 13(a) or
15(d) of the Securities  Exchange Act of 1934, and the information  contained in
the Report fairly presents,  in all material respects,  the financial  condition
and results of operations of the Company.

                                           /s/ Randall H. Pierce
                                           --------------------------
                                           Randall H. Pierce
                                           Chief Financial Officer
                                           May 8, 2003
```
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 9
<CIK> 0000883476
<NAME> CRESCENT BANKING COMPANY
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           3,918
<INT-BEARING-DEPOSITS>                             122
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                67,311
<INVESTMENTS-HELD-FOR-SALE>                     10,914
<INVESTMENTS-CARRYING>                          13,382
<INVESTMENTS-MARKET>                            14,957
<LOANS>                                         64,309
<ALLOWANCE>                                        947
<TOTAL-ASSETS>                                 168,129
<DEPOSITS>                                     115,117
<SHORT-TERM>                                    28,745
<LIABILITIES-OTHER>                              5,777
<LONG-TERM>                                      4,050
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,764
<OTHER-SE>                                      12,675
<TOTAL-LIABILITIES-AND-EQUITY>                 168,129
<INTEREST-LOAN>                                  1,520
<INTEREST-INVEST>                                  257
<INTEREST-OTHER>                                    58
<INTEREST-TOTAL>                                 3,278
<INTEREST-DEPOSIT>                               1,118
<INTEREST-EXPENSE>                               1,667
<INTEREST-INCOME-NET>                            1,611
<LOAN-LOSSES>                                       95
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                  3,466
<INCOME-PRETAX>                              (146,474)
<INCOME-PRE-EXTRAORDINARY>                   (146,474)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (94,573)
<EPS-BASIC>                                       0.05
<EPS-DILUTED>                                     0.05
<YIELD-ACTUAL>                                    9.22
<LOANS-NON>                                          0
<LOANS-PAST>                                       219
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                  1,108
<ALLOWANCE-OPEN>                                   865
<CHARGE-OFFS>                                       13
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                  865
<ALLOWANCE-DOMESTIC>                               885
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                             62


</TABLE>
<PAGE>


                                                                      Exhibit 99
                                                                      ----------

                                  Certification
            Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
       (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18,
                              United States Code)



         Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections
(a) and (b) of section 1350, chapter 63 of title 18, United States Code), each
of the undersigned officers of Opta Food Ingredients, Inc., a Deleware
corporation (the "Company"), does hereby certify, to such officer's knowledge,
that:

         The Quarterly Report on Form 10-Q for the quarter ended June 30, 2002
(the "Form 10-Q") of the Company fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, and the information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of the Company.

Dated:  August 12, 2002               /s/ Arthur J. McEvily, Ph.D.
                                      ----------------------------
                                      Arthur J. McEvily, Ph.D.
                                      President and Chief Executive Officer
                                      (principal executive officer)



Dated:  August 12, 2002               /s/ Scott A. Kumf
                                      ----------------------------
                                      Scott A. Kumf
                                      Chief Operating Officer,
                                      Chief Financial Officer and Treasurer
                                      (principal financial officer)



         The foregoing certification is being furnished solely pursuant to
section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code) and is not being filed
as a separate disclosure document.
Corey Lavell GRAHAM, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-3030

District Court of Appeal of Florida, Fifth District.

Decision filed February 13, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
John Michael KOZIK, Appellant, v. Craig HANSON, Individually and as Emergency Temporary Custodian of Alice Marie Kozik, and Teresa Hanson, Individually, and Alice Marie Kozik, Appellees.

No. 1D17-1392

District Court of Appeal of Florida, First District.

April 13, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
#### UNITED STATES of America Plaintiff-Appellee v. William O’DELL, also known as William Clayton O’Dell Defendant-Appellant

No. 17-1675

United States Court of Appeals, Eighth Circuit.

Submitted: August 1, 2017

Filed: August 10, 2017

Benjamin Wulff, Assistant U.S. Attorney, U.S. Attorney’s Office, Western District of Arkansas, Texarkana, AR, for Plaintiff-Appellee

William O’Dell, Pro Se

Before COLLOTON, MURPHY, and KELLY, Circuit Judges.

PER CURIAM.

William O’Dell directly appeals after he entered a conditional guilty plea to a charge of failing to register as a sex offender, and was sentenced by the district court1 to six months in prison followed by supervised release with conditions. Prior to entering his guilty plea, O’Dell moved to dismiss the indictment on grounds that the Sex Offender Registration and Notification Act (SORNA) is unconstitutional, in light of Nat’l Fed’n of Indep. Bus. v. Sebelius, 567 U.S. 519, 132 S.Ct. 2566, 183 L.Ed.2d 450 (2012). His motion was denied. He then entered his guilty plea pursuant to a written plea agreement that reserved his right to appeal the denial of his motion to dismiss the indictment, but waived his right to appeal his sentence unless it exceeded the statutory maximum. On appeal, his counsel has moved for leave to withdraw, and has filed a brief under Anders v. California, 386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), arguing that the district court erred by denying O’Dell’s motion to dismiss the indictment, and abused its discretion by imposing a special condition of supervised release.

We first conclude that the district court did not err by denying O’Dell’s motion to dismiss the indictment. See United States v. Howell, 552 F.3d 709, 712-17 (8th Cir. 2009) (challenge to constitutionality of federal statute is reviewed de novo; SORNA is constitutional pursuant to Congress’s authority to use necessary and proper means to further its Commerce Clause power); see also United States v. Anderson, 771 F.3d 1064, 1067-71 (8th Cir. 2014) (motion to dismiss indictment is reviewed de novo; noting that Howell remains correctly decided after Supreme Court’s decision in Nat’l Fed’n of Indep. Bus.). We further conclude that the appeal waiver is enforceable with respect to O’Dell’s challenge to the special condition of supervised release. See United States v. Scott, 627 F.3d 702, 704 (8th Cir. 2010) (validity and applicability of appeal waiver is reviewed de novo); United States v. Andis, 333 F.3d 886, 889-*17292 (8th Cir. 2003) (en banc) (discussing enforcement of appeal waiver).

Finally, having independently reviewed the record under Penson v. Ohio, 488 U.S. 75, 109 S.Ct. 346, 102 L.Ed.2d 300 (1988), we have found no nonfrivolous issues for appeal outside the scope of the appeal waiver. The judgment, is affirmed, and counsel’s motion to withdraw is granted.

1

. The Honorable Susan O. Hickey, United States District Judge for the Western District of Arkansas.
EXHIBIT 32.2 SECTION 1350 CERTIFICATION Pursuant
to 18 U.S.C. Section 1350, I, Jane Morlok, Chief Financial Officer of Breda
Telephone Corp., certify that to my knowledge (i) Breda Telephone Corp.s
Annual Report on Form 10-KSB for the fiscal year ended December 31, 2007 (the
Report) fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and (ii) the information contained in the
Report fairly presents, in all material respects, the financial condition and
results of operations of Breda Telephone Corp. Date: March
 28, 2008/s/ Jane MorlokJane Morlok, Chief
 Financial Officer E-6
<PAGE>

EXHIBIT 23.1

                         CONSENT OF INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration Statements on
Forms S-8 (File No. 333-89331, effective October 20, 1999 and File No.
333-65430, effective July 19, 2001) pertaining to the 1998 Stock Plan and the
1999 Employee Stock Purchase Plan of rStar Corporation of our report dated March
24, 2003, with respect to the consolidated financial statements of rStar
Corporation included in this annual report on Form 10-K for the year ended
December 31, 2002.







                                                       Yours Truly,


April 11, 2002                                    KOST, FORER and GABBAY
Tel-Aviv, Israel                              A Member of Ernst & Young Global
**EXHIBIT 31.1**
**CERTIFICATION**
**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**
     I, Gerald E. Bisbee, Jr., certify that:
     1. I have reviewed this quarterly report on Form 10-Q of ReGenBiologics, Inc.;
     2. Based on my knowledge, this quarterly report does not contain anyuntrue statement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered by thisreport;
     3. Based on my knowledge, the financial statements, and otherfinancial information included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theregistrant as of, and for, the periods presented in this report;
     4. The registrant’s other certifying officers and I are responsiblefor establishing and maintaining disclosure controls and procedures (as definedin Exchange Act Rules 13a — 15(e) and 15d — 15(e)) for the registrant and have:
     a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;
     b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period coveredby this report based on such evaluation; and
     c) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’s mostrecent fiscal quarter (the registrant’s fourth fiscal quarter in the case of anannual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting;and
     5. The registrant’s other certifying officers and I have disclosed,based on our most recent evaluation of internal control over financialreporting, to the registrant’s auditors and the audit committee of theregistrant’s board of directors (or persons performing the equivalentfunctions):
     a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonablylikely to adversely affect the registrant’s ability to record, process,summarize and report financial information; and
     b) Any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal control overfinancial reporting.
Date: May 14, 2004         By:  /s/ GERALD E. BISBEE, JR.    Gerald E. Bisbee, Jr.    *President andChief Executive Officer*
Wilkens SIMEON, Appellant, v. STATE of Florida, Appellee.

No. 4D17-1299

District Court of Appeal of Florida, Fourth District.

[February 22, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-29-1997
<CASH>                                               2
<SECURITIES>                                         0
<RECEIVABLES>                                   43,363
<ALLOWANCES>                                     1,144
<INVENTORY>                                     67,469
<CURRENT-ASSETS>                               118,636
<PP&E>                                          53,580
<DEPRECIATION>                                  18,164
<TOTAL-ASSETS>                                 162,238
<CURRENT-LIABILITIES>                           97,899
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            81
<OTHER-SE>                                      62,823
<TOTAL-LIABILITY-AND-EQUITY>                   162,238
<SALES>                                        128,622
<TOTAL-REVENUES>                               128,622
<CGS>                                           93,224
<TOTAL-COSTS>                                  127,852
<OTHER-EXPENSES>                                   177
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 177
<INCOME-PRETAX>                                    607
<INCOME-TAX>                                       206
<INCOME-CONTINUING>                                401
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       401
<EPS-PRIMARY>                                     0.05
<EPS-DILUTED>                                     0.05
        

</TABLE>
#### Kriesta L. WATSON, Plaintiff-Appellant, v. SHENANDOAH UNIVERSITY; Board of Trustees, Defendants-Appellees, and Bryon Grigsby; Marie Landes; Calvin Allen; Karen Abraham; Steven Humpries; Tracey Fitzsimmons, Defendants.

No. 17-1588

United States Court of Appeals, Fourth Circuit.

Submitted: September 27, 2017

Decided: October 26, 2017

*263Rriesta L. Watson, Appellant Pro Se. Catherine Jackson Huff, Paul Granger Klockenbrink, Monica Taylor Monday, GENTRY LOCKE, Roanoke, Virginia, for Appellees.

Before KING, AGEE, and KEENAN, Circuit Judges.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

Rriesta L. Watson appeals the district court’s order accepting the recommendation of the magistrate judge and granting Defendants’ motion for summary judgment in her civil action. We have reviewed the record and find no reversible error. Accordingly, we deny Watson’s motion to appoint counsel and affirm for the reasons stated by the district court. *See Watson v. Shenandoah Univ.,*No. 5:14-cv-00022-EKD-JCH, 2017 WL 1181029 (WD. Va. Mar. 29, 2017). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.

*AFFIRMED*
Scott Christopher HAHN, Appellant, v. STATE of Florida, Appellee.

Case No. 2D17-2376

District Court of Appeal of Florida, Second District.

Opinion filed February 9, 2018.

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
EXHIBIT 3.3

CERTIFICATE OF AMENDMENT TOTHE CERTIFICATE OF INCORPORATION OFAPACHE MEDICAL SYSTEMS, INC.

ONE

The Certificate of Incorporation of APACHE Medical Systems, Inc. is
amended by changing the Article thereof numbered FIRST so that, as amended,
said Article shall be and read as follows:

FIRST.   Name. The name of the corporation is Aros Corporation.

TWO

At its regular meeting held on May 14, 2001, the Board of Directors of the
corporation declared the amendment advisable, duly adopted it and recommended
it for consideration by the stockholders at their next annual meeting.

THREE

At their annual meeting duly called and held on June 11, 2001 upon notice
in accordance with Section 222 of the General Corporation Law of the State of
Delaware, the stockholders of the corporation adopted the amendment by voting
the necessary number of shares as required by statute in favor of the
amendment.

FOUR

The corporation, its Board of Directors and its stockholders duly adopted
the amendment in accordance with the provisions of Section 242 of the General
Corporation Law of the State of Delaware.

The undersigned declares that the facts herein stated are true as of July
3, 2001.

|                                                                      
|----------------------------------------------------------------------
|APACHE MEDICAL SYSTEMS, INC                                           
|                                                                      
|By:                 /s/ Gerald E. Bisbee, Jr., Ph.D.                  
|Gerald E. Bisbee, Jr., Ph.D.
      Secretary and Chairman of the Board
# Úřední věstník C 160A/27.

| | ISSN 1977-0863 |
| --- | --- |
| Úřední věstník
  Evropské unie | C 160A |
| | |
| České vydání | Informace a oznámení | Svazek 5727. května 2014 |

ISSN 1977-0863

Úřední věstník

Evropské unie

C 160A

České vydání

Informace a oznámení

Svazek 5727. května 2014

---

| Oznámeníč. | Obsah | Strana |
| --- | --- | --- |
| | V   Oznámení |
| | SPRÁVNÍ ŘÍZENÍ |
| | Evropská agentura pro léčivé přípravky |
| 2014/C 160A/01 | Oznámení o zrušení | 1 |

Oznámeníč.

Obsah

Strana

V   Oznámení

SPRÁVNÍ ŘÍZENÍ

Evropská agentura pro léčivé přípravky

2014/C 160A/01

Oznámení o zrušení

1

| | |
| --- | --- |
| 2014/C 160A/02 | Přehled výběrových řízení zveřejněných v řadě C A úředního věstníku | 2 |

2014/C 160A/02

Přehled výběrových řízení zveřejněných v řadě C A úředního věstníku

2

| CS | |
| --- | --- |

CS

---

V Oznámení

SPRÁVNÍ ŘÍZENÍ

Evropská agentura pro léčivé přípravky

| 27.5.2014 | CS | Úřední věstník Evropské unie | CA 160/1 |
| --- | --- | --- | --- |

27.5.2014

CS

Úřední věstník Evropské unie

CA 160/1

---

Oznámení o zrušení

2014/C 160 A/01

Evropská agentura pro léčivé přípravky se rozhodla zrušit toto výběrové řízení:

| — | EMA/AD/359: Vedoucí oddělení IT operací, odbor informačních technologií (AD 10) |
| --- | --- |

—

EMA/AD/359: Vedoucí oddělení IT operací, odbor informačních technologií (AD 10)

---

27.5.2014

| 27.5.2014 | CS | Úřední věstník Evropské unie | CA 160/2 |
| --- | --- | --- | --- |

CS

Úřední věstník Evropské unie

CA 160/2

---

PŘEHLED VÝBĚROVÝCH ŘÍZENÍ ZVEŘEJNĚNÝCH V ŘADĚ C A ÚŘEDNÍHO VĚSTNÍKU

2014/C 160 A/02

Níže najdete seznam Úředních věstníků řady C A publikovaných v tomto roce.

Pokud není uvedeno jinak, jsou Úřední věstníky publikovány ve všech jazykových verzích.

| 5 | |
| --- | --- |
| 6 | |
| 11 | |
| 19 | |
| 21 | |
| 26 | |
| 27 | |
| 30 | (PL) |
| 35 | |
| 41 | (DE/EN/FR) |
| 42 | |
| 43 | |
| 46 | |
| 47 | |
| 48 | |
| 55 | |
| 56 | |
| 60 | |
| 62 | |
| 65 | |
| 73 | (DE/EN/FR) |
| 74 | |
| 81 | |
| 88 | |
| 92 | (DE/EN/FR) |
| 97 | |
| 98 | |
| 99 | |
| 108 | |
| 109 | |
| 116 | |
| 119 | |
| 133 | |
| 134 | |
| 136 | |
| 137 | (DE/EN/FR) |
| 140 | |
| 145 | |
| 152 | |
| 160 | |

5

6

11

19

21

26

27

30

(PL)

35

41

(DE/EN/FR)

42

43

46

47

48

55

56

60

62

65

73

(DE/EN/FR)

74

81

88

92

(DE/EN/FR)

97

98

99

108

109

116

119

133

134

136

137

(DE/EN/FR)

140

145

152

160

---